Levomefolic acid Completed Phase 4 Trials for Polycystic Ovarian Syndrome (PCOS) Treatment

Indications	Status	Purpose	Phase
DBCOND0062250 (Polycystic Ovarian Syndrome (PCOS))	Completed	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT01360996	Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism	Drospirenone (DB01395) Ethinylestradiol (DB00977) Folic acid (DB00158) Levomefolic acid (DB11256)